10 year follow up of rituximab and lenalidomide in low tumor burden FL
Nathan Fowler • 12 Dec 2021
ZUMA-1, JULIET and TRANSCEND trials: changing the treatment landscape for R/R NHL
David Maloney • 4 Jan 2019
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.